Shrinkage of the non-malignant prostate gland volume after receiving incidental radiotherapy for rectal cancer.

Kovarik, Josef; Kelly, Charles; West, Nick; Drinnan, Michael; Dobrowsky, Werner; Iqbal, Muhammad Shahid

Kovarik, Josef; Kelly, Charles; West, Nick; Drinnan, Michael; Dobrowsky, Werner; Iqbal, Muhammad Shahid.

Afiliação

Kovarik J; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Kelly C; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
West N; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Drinnan M; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Dobrowsky W; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Iqbal MS; Northern Centre for Cancer Care, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Rep Pract Oncol Radiother ; 27(3): 577-582, 2022.

Article em En | MEDLINE | ID: mdl-36186705

Palavras-chave

benign disease; prostate hyperplasia; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Rep Pract Oncol Radiother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google